Product Information
THYROID 30 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.5917 per EA under NDC 62559074101. Its NADAC has been published 124 times since May 22, 2024.
Strength
30 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559074101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
THYROIDApproval Type
Unapproved
On Market Since
6/15/2023
Price Statistics
The NADAC for THYROID 30 MG TABLET has been published 124 times since May 22, 2024, and over the history we have for it it has risen 6.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5917 per EA |
|---|---|
| All-time high | $0.6286 (Jul 10, 2024) |
| All-time low | $0.5358 (Nov 20, 2024) |
| 52-week high | $0.5962 |
| 52-week low | $0.5717 |
| Median price | $0.5917 |
| Average price | $0.5936 |
| Largest weekly change | -14.3% (Nov 20, 2024) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Thyroid market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Thyroid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of THYROID 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for THYROID 30 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.5917 per EA (NDC 62559074101), effective Sep 30, 2026.
How has the price of THYROID 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for THYROID 30 MG TABLET has risen 6.3%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for THYROID 30 MG TABLET?
Since May 22, 2024, the NADAC for THYROID 30 MG TABLET has ranged from a low of $0.5358 (Nov 20, 2024) to a high of $0.6286 (Jul 10, 2024), with a median of $0.5917 per EA.
Are there cheaper alternatives to THYROID 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of THYROID 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures THYROID 30 MG TABLET?
THYROID 30 MG TABLET (NDC 62559074101) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.